Article
Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
The Pediatric infectious disease journal - 1 Apr 2009
De Vos Beatrice, Han Htay Htay, Bouckenooghe Alain, Debrus Serge, Gillard Paul, Ward Richard, Cheuvart Brigitte
Abstract excerpt
BACKGROUND: : The 2-dose, oral live attenuated human G1P[8] rotavirus vaccine (RIX4414) is highly effective against rotavirus gastroenteritis caused by circulating G1 and non-G1 types. An integrated analysis on vaccine efficacy was undertaken to obtain more precise estimates of the overall protective effect of the RIX4414 vaccine against rotavirus gastroenteritis due to common rotavirus types (G1, G3, G4, G9,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.